<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02534701</url>
  </required_header>
  <id_info>
    <org_study_id>ERASER</org_study_id>
    <nct_id>NCT02534701</nct_id>
  </id_info>
  <brief_title>ERic Acute StrokE Recanalization (ERASER)</brief_title>
  <acronym>ERASER</acronym>
  <official_title>ERic Acute StrokE Recanalization (ERASER)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To monitor the effect of the ERIC® device in combination with SOFIA™ Distal Access Catheter
      on artery recanalization and on clinical outcomes in stroke patients using data from clinical
      routine application (ERASER).

      To additionally evaluate the effect of the ERIC® device in combination with SOFIA™ Distal
      Access Catheter on the final infarct volume as determined by advanced image postprocessing
      methods in the subgroup of patients with acute middle cerebral artery stroke (ERASER+).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, international, single-arm, controlled, open label post-market,
      multicenter study to compare the safety and effectiveness of ERIC® device in combination with
      SOFIA™ Distal Access Catheter in acute ischemic stroke patients using clinical routine data.

      Patients who meet the imaging inclusion criteria for ERASER will be included in the cohort
      where collected and additionally analyzed data will be compared to a historical patient
      cohort (referred to as ERASER imaging =ERASER+). All other patients will be included in a
      registry (referred to as ERASER), where clinical information will be collected. The overall
      study duration is expected to be 18 Months. The expected duration of each subject's enrolment
      is approximately 90 days. Subjects will be followed with assessments at 90 days post stroke.

      The basic concept of ERASER+ is the use an infarct prediction algorithm that has been trained
      on a large dataset of historical imaging data of patients treated with IV tPA, apply it to
      the pre-treatment imaging and compare its predictions with the actual outcome.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2015</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">April 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>VOST (volume of saved tissue) = VPIv- VMT</measure>
    <time_frame>30 h</time_frame>
    <description>volume of saved tissue (VOST) as difference of the brain volume with an infarct risk of &gt;50%, based on a prediction- algorithm trained in a historical cohort treated with IV tPA (VPIv) and the actual infarct volume</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>mRS≤2</measure>
    <time_frame>90 days</time_frame>
    <description>neurological outcomes (mRS≤2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NIHSS score improvement ≥10 from baseline</measure>
    <time_frame>90 days</time_frame>
    <description>neurological outcomes (NIHSS score improvement ≥10 from baseline)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">53</enrollment>
  <condition>Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>ERIC® and SOFIA™</arm_group_label>
    <description>ERIC® device in combination with SOFIA™ Distal Access Catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ERIC® and SOFIA™</intervention_name>
    <description>a self-expanding clot retrieval system</description>
    <arm_group_label>ERIC® and SOFIA™</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients over 18 year with acute ischemic stroke
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute ischemic stroke with NIH-SS score of 8-25

          -  CTP/ MRP &lt;4.5h after symptom onset completed

          -  CTA/ MRA confirms M1-occlusion

          -  Groin puncture estimated &lt;6h after stroke onset

          -  Intended usage of ERIC® as first device in combination with SOFIA™ Distal Access
             -Catheter (secondary bail-out with other devices allowed)

        Exclusion Criteria:

          -  MCA &gt;1/3 abnormal in DWI or CBV (ASPECTS ≤ 7, &gt;100 mL)

          -  Pre stroke mRS ≥ 2

          -  Necessity of ipsilateral internal carotid artery (ICA) angioplasty

          -  Age &lt;18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens Fiehler, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitätsklinikum Augsburg</name>
      <address>
        <city>Augsburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Dortmund</name>
      <address>
        <city>Dortmund</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universität Greifswald</name>
      <address>
        <city>Greifswald</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinik Altona</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig-Holstein</name>
      <address>
        <city>Lübeck</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universität München</name>
      <address>
        <city>München</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kantonspital Aarau</name>
      <address>
        <city>Aarau</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 25, 2015</study_first_submitted>
  <study_first_submitted_qc>August 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 28, 2015</study_first_posted>
  <last_update_submitted>October 9, 2017</last_update_submitted>
  <last_update_submitted_qc>October 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>clot retrieval system</keyword>
  <keyword>recanalization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

